• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸酶 PRL-3 参与癌症转移的关键步骤。

The Phosphatase PRL-3 Is Involved in Key Steps of Cancer Metastasis.

机构信息

Institut Curie, PSL Research University, Centre National de La Recherche Scientifique (CNRS), Institut National de la Santé Et de la Recherche Médicale (INSERM), Unité Mixte de Recherche 3347 (UMR), Unité 1021, Orsay, France; Université Paris Sud, Université Paris-Saclay Centre National de La Recherche Scientifique, Unité Mixte de Recherche 3347, Unité 1021, Orsay, France.

Institut Curie, PSL Research University, F-75005 @Paris, France; INSERM, U900, F-75005 Paris, France; MINES ParisTech, PSL Research University CBIO-Centre for Computational Biology, F-75006 Paris, France.

出版信息

J Mol Biol. 2019 Aug 9;431(17):3056-3067. doi: 10.1016/j.jmb.2019.06.008. Epub 2019 Jun 14.

DOI:10.1016/j.jmb.2019.06.008
PMID:31207239
Abstract

PRL-3 belongs to the PRL phosphatase family. Its physiological role remains unclear, but many studies have identified that PRL-3 is a marker of cancer progression and shown it to be associated with metastasis. Evidence implicating PRL-3 in various elements of the metastatic process, such as the cell cycle, survival, angiogenesis, adhesion, cytoskeleton remodeling, EMT, motility and invasion, has been reported. Furthermore, several molecules acting as direct or indirect substrates have been identified. However, this information was obtained in many different studies, and it remains difficult to see the larger picture. We therefore systematically collected the published information together and used it to develop a comprehensive signaling network map. By analyzing this network map, we were able to retrieve the signaling pathways via which PRL-3 governs the key steps of the metastatic process in cancer. In this review, we summarize current knowledge of the role of PRL-3 in cancer and the molecular mechanisms involved. We also provide the web-based open-source PRL-3 signaling network map, for use in further studies.

摘要

PRL-3 属于 PRL 磷酸酶家族。其生理作用尚不清楚,但许多研究已经确定 PRL-3 是癌症进展的标志物,并表明它与转移有关。有证据表明 PRL-3 参与转移过程的各个环节,如细胞周期、存活、血管生成、黏附、细胞骨架重塑、EMT、运动和侵袭。此外,已经确定了几种作为直接或间接底物的分子。然而,这些信息是在许多不同的研究中获得的,因此仍然很难看到全貌。因此,我们系统地收集了已发表的信息,并将其用于开发全面的信号网络图谱。通过分析这个网络图,我们能够检索出 PRL-3 控制癌症转移过程中关键步骤的信号通路。在这篇综述中,我们总结了 PRL-3 在癌症中的作用及其涉及的分子机制。我们还提供了基于网络的开源 PRL-3 信号网络图谱,供进一步研究使用。

相似文献

1
The Phosphatase PRL-3 Is Involved in Key Steps of Cancer Metastasis.磷酸酶 PRL-3 参与癌症转移的关键步骤。
J Mol Biol. 2019 Aug 9;431(17):3056-3067. doi: 10.1016/j.jmb.2019.06.008. Epub 2019 Jun 14.
2
PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.泌乳素-3(PRL-3)在三阴性乳腺癌细胞中激活粘着斑通路,以改变对细胞迁移和侵袭至关重要的肌动蛋白结构和底物粘附特性。
Cancer Lett. 2016 Oct 1;380(2):505-512. doi: 10.1016/j.canlet.2016.07.017. Epub 2016 Jul 21.
3
PRL-3 phosphatase and cancer metastasis.PRL-3 磷酸酶与癌症转移。
J Cell Biochem. 2010 Dec 1;111(5):1087-98. doi: 10.1002/jcb.22913.
4
PRL-3: a metastasis-associated phosphatase in search of a function.PRL-3:一种寻找功能的转移相关磷酸酶。
Cells Tissues Organs. 2007;185(1-3):232-6. doi: 10.1159/000101324.
5
PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.催乳素酪氨酸磷酸酶调节Rho家族小GTP酶以促进侵袭和运动。
Cancer Res. 2006 Mar 15;66(6):3153-61. doi: 10.1158/0008-5472.CAN-05-3116.
6
Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.升高的肝再生磷酸酶 3(PRL-3)促进了内异症子宫内膜基质细胞中细胞骨架的重排、细胞迁移和侵袭。
Hum Reprod. 2016 Apr;31(4):723-33. doi: 10.1093/humrep/dew015. Epub 2016 Feb 13.
7
PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis.PRL-3,一种新兴的致癌标志物,与不良预后密切相关。
Anticancer Agents Med Chem. 2011 Jan;11(1):99-108. doi: 10.2174/187152011794941145.
8
Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.Stathmin,一种通过蛋白质组学方法鉴定的 PRL-3 的新靶点,在结直肠癌的进展和转移中发挥关键作用。
J Proteome Res. 2010 Oct 1;9(10):4897-905. doi: 10.1021/pr100712t.
9
Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.基于硫代罗丹宁的 PRL-3 抑制剂可阻断转移性癌细胞的迁移和侵袭。
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3769-74. doi: 10.1016/j.bmcl.2013.04.092. Epub 2013 May 9.
10
Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.再生肝脏磷酸酶-3通过调节上皮-间质转化抑制非小细胞肺癌的侵袭和增殖。
Oncotarget. 2016 Apr 19;7(16):21799-811. doi: 10.18632/oncotarget.7985.

引用本文的文献

1
The PACT Network: PRL, ARL, CNNM, and TRPM Proteins in Magnesium Transport and Disease.PACT网络:泌乳素、雄激素受体样蛋白、阳离子扩散促进蛋白和瞬时受体电位阳离子通道蛋白在镁转运及疾病中的作用
Int J Mol Sci. 2025 Feb 12;26(4):1528. doi: 10.3390/ijms26041528.
2
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond.从酪氨酸激酶到酪氨酸磷酸酶:癌症及其他领域的新治疗靶点
Pharmaceutics. 2024 Jul 1;16(7):888. doi: 10.3390/pharmaceutics16070888.
3
Role of Protein Phosphatases in Tumor Angiogenesis: Assessing PP1, PP2A, PP2B and PTPs Activity.
蛋白磷酸酶在肿瘤血管生成中的作用:评估 PP1、PP2A、PP2B 和 PTPs 的活性。
Int J Mol Sci. 2024 Jun 22;25(13):6868. doi: 10.3390/ijms25136868.
4
MicroRNA-495: a therapeutic and diagnostic tumor marker.微小 RNA-495:一种治疗和诊断肿瘤的标志物。
J Mol Histol. 2023 Dec;54(6):559-578. doi: 10.1007/s10735-023-10159-0. Epub 2023 Sep 28.
5
Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma.抗PRL-3单克隆抗体抑制结直肠癌的生长和转移。
J Cancer. 2023 Aug 21;14(13):2585-2595. doi: 10.7150/jca.81702. eCollection 2023.
6
Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.再生肝脏磷酸酶3(PRL-3)的磷酸酶和假磷酸酶功能在体外对二价金属不敏感。
ACS Omega. 2023 Aug 9;8(33):30578-30589. doi: 10.1021/acsomega.3c04095. eCollection 2023 Aug 22.
7
Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3.开发并鉴定能够特异性靶向致癌性肝再生磷酸酶-3(PRL-3)的纳米抗体,并影响其与已知结合伴侣 CNNM3 的相互作用。
PLoS One. 2023 May 23;18(5):e0285964. doi: 10.1371/journal.pone.0285964. eCollection 2023.
8
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.PRL3 作为多种癌症新型癌症免疫疗法的治疗靶点。
Theranostics. 2023 Mar 21;13(6):1876-1891. doi: 10.7150/thno.79265. eCollection 2023.
9
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.靶向蛋白磷酸酶治疗癌症免疫治疗和自身免疫性疾病。
Nat Rev Drug Discov. 2023 Apr;22(4):273-294. doi: 10.1038/s41573-022-00618-w. Epub 2023 Jan 24.
10
Characterizing /PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma.将/PRL-3鉴定为肝细胞癌潜在的预后标志物基因
J Oncol. 2022 Sep 30;2022:2717056. doi: 10.1155/2022/2717056. eCollection 2022.